Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Acute Myeloid Leukemia Treatment
1.2 Key Market Segments
1.2.1 Acute Myeloid Leukemia Treatment Segment by Type
1.2.2 Acute Myeloid Leukemia Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Acute Myeloid Leukemia Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Acute Myeloid Leukemia Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Acute Myeloid Leukemia Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Acute Myeloid Leukemia Treatment Market Competitive Landscape
3.1 Global Acute Myeloid Leukemia Treatment Sales by Manufacturers (2019-2024)
3.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Acute Myeloid Leukemia Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Acute Myeloid Leukemia Treatment Sales Sites, Area Served, Product Type
3.6 Acute Myeloid Leukemia Treatment Market Competitive Situation and Trends
3.6.1 Acute Myeloid Leukemia Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Acute Myeloid Leukemia Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Acute Myeloid Leukemia Treatment Industry Chain Analysis
4.1 Acute Myeloid Leukemia Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Acute Myeloid Leukemia Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Acute Myeloid Leukemia Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Acute Myeloid Leukemia Treatment Sales Market Share by Type (2019-2024)
6.3 Global Acute Myeloid Leukemia Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Acute Myeloid Leukemia Treatment Price by Type (2019-2024)
7 Acute Myeloid Leukemia Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Acute Myeloid Leukemia Treatment Market Sales by Application (2019-2024)
7.3 Global Acute Myeloid Leukemia Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Acute Myeloid Leukemia Treatment Sales Growth Rate by Application (2019-2024)
8 Acute Myeloid Leukemia Treatment Market Segmentation by Region
8.1 Global Acute Myeloid Leukemia Treatment Sales by Region
8.1.1 Global Acute Myeloid Leukemia Treatment Sales by Region
8.1.2 Global Acute Myeloid Leukemia Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Acute Myeloid Leukemia Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Acute Myeloid Leukemia Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Acute Myeloid Leukemia Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Acute Myeloid Leukemia Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Acute Myeloid Leukemia Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ambit Biosciences Corporation
9.1.1 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Basic Information
9.1.2 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product Overview
9.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product Market Performance
9.1.4 Ambit Biosciences Corporation Business Overview
9.1.5 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment SWOT Analysis
9.1.6 Ambit Biosciences Corporation Recent Developments
9.2 Celgene Corporation
9.2.1 Celgene Corporation Acute Myeloid Leukemia Treatment Basic Information
9.2.2 Celgene Corporation Acute Myeloid Leukemia Treatment Product Overview
9.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Product Market Performance
9.2.4 Celgene Corporation Business Overview
9.2.5 Celgene Corporation Acute Myeloid Leukemia Treatment SWOT Analysis
9.2.6 Celgene Corporation Recent Developments
9.3 Cephalon
9.3.1 Cephalon Acute Myeloid Leukemia Treatment Basic Information
9.3.2 Cephalon Acute Myeloid Leukemia Treatment Product Overview
9.3.3 Cephalon Acute Myeloid Leukemia Treatment Product Market Performance
9.3.4 Cephalon Acute Myeloid Leukemia Treatment SWOT Analysis
9.3.5 Cephalon Business Overview
9.3.6 Cephalon Recent Developments
9.4 Clavis Pharma
9.4.1 Clavis Pharma Acute Myeloid Leukemia Treatment Basic Information
9.4.2 Clavis Pharma Acute Myeloid Leukemia Treatment Product Overview
9.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Product Market Performance
9.4.4 Clavis Pharma Business Overview
9.4.5 Clavis Pharma Recent Developments
9.5 Eisai
9.5.1 Eisai Acute Myeloid Leukemia Treatment Basic Information
9.5.2 Eisai Acute Myeloid Leukemia Treatment Product Overview
9.5.3 Eisai Acute Myeloid Leukemia Treatment Product Market Performance
9.5.4 Eisai Business Overview
9.5.5 Eisai Recent Developments
9.6 Genzyme Corporation
9.6.1 Genzyme Corporation Acute Myeloid Leukemia Treatment Basic Information
9.6.2 Genzyme Corporation Acute Myeloid Leukemia Treatment Product Overview
9.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Product Market Performance
9.6.4 Genzyme Corporation Business Overview
9.6.5 Genzyme Corporation Recent Developments
9.7 Sunesis Pharmaceuticals
9.7.1 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Basic Information
9.7.2 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product Overview
9.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product Market Performance
9.7.4 Sunesis Pharmaceuticals Business Overview
9.7.5 Sunesis Pharmaceuticals Recent Developments
10 Acute Myeloid Leukemia Treatment Market Forecast by Region
10.1 Global Acute Myeloid Leukemia Treatment Market Size Forecast
10.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Acute Myeloid Leukemia Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Acute Myeloid Leukemia Treatment Market Size Forecast by Region
10.2.4 South America Acute Myeloid Leukemia Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Acute Myeloid Leukemia Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Acute Myeloid Leukemia Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Acute Myeloid Leukemia Treatment by Type (2025-2030)
11.1.2 Global Acute Myeloid Leukemia Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Acute Myeloid Leukemia Treatment by Type (2025-2030)
11.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Acute Myeloid Leukemia Treatment Sales (K Units) Forecast by Application
11.2.2 Global Acute Myeloid Leukemia Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings